PMBCX
Price
$30.26
Change
-$0.18 (-0.59%)
Updated
Jun 2 closing price
Net Assets
24.56B
SMFYX
Price
$38.08
Change
+$0.26 (+0.69%)
Updated
Jun 2 closing price
Net Assets
699.23M
Interact to see
Advertisement

PMBCX vs SMFYX

Header iconPMBCX vs SMFYX Comparison
Open Charts PMBCX vs SMFYXBanner chart's image
PMBCX vs SMFYX Comparison Chart in %
View a ticker or compare two or three
VS
PMBCX vs. SMFYX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PMBCX is a Buy and SMFYX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMBCX has more cash in the bank: 24.6B vs. SMFYX (699M). PMBCX (0.00) and SMFYX (0.00) have matching dividends . PMBCX was incepted earlier than SMFYX: PMBCX (19 years) vs SMFYX (14 years). PMBCX (1.71) is less costly to investors than SMFYX (1.00). SMFYX is a more actively managed with annual turnover of: 51.00 vs. PMBCX (13.70). PMBCX has a lower initial minimum investment than SMFYX: PMBCX (1000) vs SMFYX (100000). SMFYX annual gain was more profitable for investors over the last year : -2.18 vs. PMBCX (-15.11). SMFYX return over 5 years is better than : 0.93 vs. PMBCX (-9.16).
PMBCXSMFYXPMBCX / SMFYX
Total Expense Ratio1.710.95180%
Annual Report Gross Expense Ratio1.711.00171%
Fund Existence19 years14 years-
Gain YTD-7.25211.737-62%
Front LoadN/AN/A-
Min. Initial Investment10001000001%
Min. Initial Investment IRAN/AN/A-
Net Assets24.6B699M3,519%
Annual Yield % from dividends0.000.00-
Returns for 1 year-15.11-2.18692%
Returns for 3 years9.9724.1241%
Returns for 5 years-9.160.93-988%
Returns for 10 years53.20110.6848%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GETGX48.02N/A
N/A
Victory Sycamore Established Value R
BRSDX16.51N/A
N/A
MFS Blended Research Small Cap Eq A
USISX20.28N/A
N/A
Victory Income Stock
CIPSX17.31N/A
N/A
Champlain Small Company Adv
SRFMX12.36N/A
N/A
Sarofim Equity